Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artivion (AORT) Total Non-Current Liabilities (2016 - 2025)

Artivion (AORT) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $427.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 7.08% year-over-year to $427.5 million, compared with a TTM value of $427.5 million through Dec 2025, down 7.08%, and an annual FY2025 reading of $427.5 million, down 7.08% over the prior year.
  • Total Non-Current Liabilities was $427.5 million for Q4 2025 at Artivion, up from $382.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $503.3 million in Q4 2023 and bottomed at $365.8 million in Q2 2025.
  • Average Total Non-Current Liabilities over 5 years is $450.3 million, with a median of $446.5 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities soared 36.29% in 2021, then decreased 18.04% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $442.9 million in 2021, then rose by 6.44% to $471.4 million in 2022, then increased by 6.75% to $503.3 million in 2023, then dropped by 8.59% to $460.0 million in 2024, then fell by 7.08% to $427.5 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for AORT at $427.5 million in Q4 2025, $382.4 million in Q3 2025, and $365.8 million in Q2 2025.